Pfizer Inc is not in talks with Chinese authorities to licence a generic version of its Covid-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive Albert Bourla said on Monday (Jan 9). Reuters reported on Friday that China was in talks with Pfizer to secure a licence that will allow...
Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease , is displayed in this picture illustration taken on Oct 7, 2022. A morning and an evening does consists of one white 100mg tablet of Ritonavir and two pink 150mg tablets of PF-07321332.
Bourla said the company had shipped thousands of courses of the treatment in 2022 to China and in the past couple of weeks, had increased that to millions. "They are the second highest economy in the world and I don't think that they should pay less than El Salvador," Bourla said. The failure of the talks to include Pfizer in the list of medicines covered by basic state health insurance generated heated discussions on Chinese social media on Monday.
Pfizer declined to comment on the Chinese media reports about the price it quoted during the negotiations. NHSA did not immediately reply to a Reuters request for comment on the negotiations.China's state media Global Times accused Pfizer of trying to profiteer from China's Covid-19 battle in an opinion piece on Monday.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer's Paxlovid not included in China's national insuranceTAIPEI, Taiwan: China's health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive. Paxlovid, an oral medicine developed by New York-based dru
続きを読む »
Pfizer CEO says there will be no generic Paxlovid for ChinaTalks with China broke off after it asked for a lower price than Pfizer is charging for most lower middle income countries. Read more at straitstimes.com.
続きを読む »
China says talks to include Paxlovid in its health insurance drug list failThe antiviral drug is currently covered by China's broad healthcare insurance scheme under temporary measures. Read more at straitstimes.com.
続きを読む »
Protesters clash with police at COVID-19 antigen kit maker factory in ChinaSHANGHAI: Protesters clashed with police in central China during a demonstration on Saturday (Jan 7) by hundreds of people at a factory producing COVID-19 antigen kits, several videos posted to social media showed. Online users said the protest was over wages and the layoff of several workers by the manufa
続きを読む »
China’s international air travel resumes, but Covid-19 turbulence to delay takeoffBEIJING - China is reopening its borders that have been largely shut for the last three years, scrapping quarantine requirements for inbound travellers and removing restrictions on international flights. Read more at straitstimes.com.
続きを読む »
Germany, Belgium, Luxembourg discourage travel to Covid-hit ChinaBERLIN, Germany - Germany, Belgium and Luxembourg on Saturday discouraged non-essential trips to China, the world's most populous nation, as it struggles with
続きを読む »